Study for genetic eye surface stem cell problems
Part of Eyes & vision clinical trials.
This trial studies people whose eye surface problems are caused by an inherited (genetic) condition. It aims to better understand how specific genetic changes relate to symptoms, which may guide more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic (inherited) condition affecting the surface of your eye
- Your main eye problem is not mainly from damage to the retina (the back of the eye)
- You are not currently pregnant
- You are not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an eye treatment made from your own cornea surface cells, grown in a lab and put back into the eye. It may help people with limbal stem cell deficiency by improving the health of the eye surface after a cell biopsy.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This study tracks people with various eye surface diseases to see which factors best predict future eyesight. It may help doctors identify who is at risk for vision loss and tailor treatments.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This study uses whole exome and whole genome genetic tests to look for DNA changes linked to inherited or congenital eye problems. It may help families and doctors better understand the cause of the eye condition and guide future care.
Hear when a new Limbus Corneae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.